Lokivetmab

• Target :

  Interleukin

• Related Pathways :

  Immunology/Inflammation

• Bioactivity :

  Lokivetmab, an Anti-Canine IL31 Recombinant Antibody, is a monoclonal antibody targeting canine IL-31, utilized in research related to atopic dermatitis (AD) in dogs [1].

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1533403-95-0